Paper2983262
Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis.
Larsen PD and 2 others. Neurology, 1985. Cited by 113 papers, by iCite.
Cite this record
ConductScience Library. Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis. Papers, record 2983262. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2983262
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Viral | Major topic |
| Antigens, Viral | Major topic |
| Capsid | Major topic |
| Herpesvirus 4, Human | Major topic |
| Multiple Sclerosis | Major topic |
| Adolescent | |
| Adult | |
| Antibodies, Antinuclear | |
| Female | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| NRR-64 | NINR NIH HHS | United States | PubMed |
Source PubMed
Cited by47
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 113 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42806375 | The influence of anti-CD20-directed B cell depletion across different agents on Epstein-Barr virus-specific humoral and cellular immunity in patients with multiple sclerosis. | J Neuroinflammation | 2026 | https://conductscience.org/library/papers/42806375 | PubMed |
| 41723725 | The CNS Meninges and the Synovial Joint: Parallel Immunological Structures in Autoimmune Disease. | Bioessays | 2026 | https://conductscience.org/library/papers/41723725 | PubMed |
| 41445616 | Host Genetic Architecture between Epstein-Barr Virus Activity and Multiple Sclerosis Reveals Shared Pathways. | medRxiv | 2025 | https://conductscience.org/library/papers/41445616 | PubMed |
| 41229156 | Retrospective In Silico Analysis of Routine Laboratory Data Supports a Specific Association of Epstein-Barr Virus and Multiple Sclerosis. | Eur J Neurol | 2025 | https://conductscience.org/library/papers/41229156 | PubMed |
| 40953326 | Epstein-Barr Virus in Multiple Sclerosis: Past, Present, and Future. | Neurol Neuroimmunol Neuroinflamm | 2025 | https://conductscience.org/library/papers/40953326 | PubMed |
| 40828536 | Epstein-Barr Virus Seropositivity, Immune Dysregulation, and Mortality in Pediatric Sepsis. | JAMA Netw Open | 2025 | https://conductscience.org/library/papers/40828536 | PubMed |
| 40568785 | Gastrointestinal inflammation and cancer: viral and bacterial interplay. | Gut Microbes | 2025 | https://conductscience.org/library/papers/40568785 | PubMed |
| 40021419 | The epidemiology, pathology and pathogenesis of MS: Therapeutic implications. | Neurotherapeutics | 2025 | https://conductscience.org/library/papers/40021419 | PubMed |
| 39817754 | Multiple sclerosis and infection: history, EBV, and the search for mechanism. | Microbiol Mol Biol Rev | 2025 | https://conductscience.org/library/papers/39817754 | PubMed |
| 38921797 | Cytomegalovirus, Epstein-Barr Virus, Herpes Simplex Virus, and Varicella Zoster Virus Infection Dynamics in People with Multiple Sclerosis from Northern Italy. | Pathogens | 2024 | https://conductscience.org/library/papers/38921797 | PubMed |
| 38002068 | From Animal Models to Clinical Trials: The Potential of Antimicrobials in Multiple Sclerosis Treatment. | Biomedicines | 2023 | https://conductscience.org/library/papers/38002068 | PubMed |
| 37841344 | Pediatric multiple sclerosis: an integrated outlook at the interplay between genetics, environment and brain-gut dysbiosis. | AIMS Neurosci | 2023 | https://conductscience.org/library/papers/37841344 | PubMed |
| 37374092 | The Role of Microorganisms in the Etiopathogenesis of Demyelinating Diseases. | Life (Basel) | 2023 | https://conductscience.org/library/papers/37374092 | PubMed |
| 37317236 | Markers of Epstein-Barr Virus Infection in Patients with Multiple Sclerosis. | Microorganisms | 2023 | https://conductscience.org/library/papers/37317236 | PubMed |
| 37108566 | Epstein-Barr Virus and Multiple Sclerosis: A Convoluted Interaction and the Opportunity to Unravel Predictive Biomarkers. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37108566 | PubMed |
| 36992490 | The Role of Viral Infections in the Onset of Autoimmune Diseases. | Viruses | 2023 | https://conductscience.org/library/papers/36992490 | PubMed |
| 36759741 | Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications. | Nat Rev Neurol | 2023 | https://conductscience.org/library/papers/36759741 | PubMed |
| 36168073 | Similar Time Trends of Hodgkin Lymphoma, Multiple Sclerosis, and Inflammatory Bowel Disease. | Dig Dis Sci | 2023 | https://conductscience.org/library/papers/36168073 | PubMed |
| 34305896 | The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis. | Front Immunol | 2021 | https://conductscience.org/library/papers/34305896 | PubMed |
| 33121451 | Prevalence of seropositivity of selected herpesviruses in patients with multiple sclerosis in the North of Jordan. | BMC Neurol | 2020 | https://conductscience.org/library/papers/33121451 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2983262
GET https://conductscience.org/api/papers/v1/2983262/cited_by?page=2